The top Democrats on key House committees are calling for “swift action” from the Drug Enforcement Administration (DEA) to reschedule marijuana—and they want federal agencies to “continue to assess” whether further reform, including full descheduling of cannabis, “may be appropriate.”
In a letter sent to Attorney General Merrick Garland and DEA Administrator Anne Milgram on Tuesday, House Judiciary Committee Ranking Member Jerrold Nadler (D-NY) and Energy & Commerce Committee Ranking Member Frank Pallone (D-NJ) stressed that the scientific review directed by the Biden administration demonstrated that cannabis has “less potential for abuse than other drugs” and “accepted medical use in treatment.”
The findings “correspond” with the U.S. Department of Health and Human Services (HHS) and Justice Department recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), they said.
“We value the Department of Justice’s steadfast commitment to prevent the misuse and diversion of controlled substances that pose a threat to public health,” the lawmakers wrote. “Amidst a devastating opioid and overdose crisis, it is imperative that law enforcement and public health agencies focus efforts on the biggest threats to Americans.”
“When Congress passed the CSA, it recognized that our scientific and medical understanding
Read full article on Marijuana Moment
